Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 1507 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
  Instructions 
  Search 
  IPS 
  My preferences 

 


This article has been cited by
1Progress in drug development for Alzheimer's disease: An overview in relation to mitochondrial energy metabolism
Jana Hroudová,Namrata Singh,Zdenek Fišar,Kallol K. Ghosh
European Journal of Medicinal Chemistry.2016;121()774
[DOI]
2Current Trends in the Development of Drugs for the Treatment of Alzheimer’s Disease and their Clinical Trials
S.O. Bachurin,E.V. Bovina,A.A. Ustyugov
Biomedical Chemistry: Research and Methods.2018;1(3)e00015
[DOI]
3Reactive Astrocytes as Drug Target in Alzheimer’s Disease
Brhane Teklebrhan Assefa,Abadi Kahsu Gebre,Birhanetensay Masresha Altaye
BioMed Research International.2018;2018(3)1
[DOI]
4Blood–brain and blood–cerebrospinal fluid passage of BRICHOS domains from two molecular chaperones in mice
Simone Tambaro,Lorena Galan-Acosta,Axel Leppert,Gefei Chen,Henrik Biverstål,Jenny Presto,Per Nilsson,Jan Johansson
Journal of Biological Chemistry.2019;294(8)2606
[DOI]
5Re-mention of an old neurodegenerative disease: Alzheimer’s disease
Peng Zhang,Ursula Adams,ZengQiang Yuan
Chinese Science Bulletin.2013;58(15)1731
[DOI]
6Effect of human APP gene overexpression on Drosophila melanogaster cholinergic and dopaminergic brain neurons
O. I. Bolshakova,A. A. Zhuk,D. I. Rodin,G. A. Kislik,S. V. Sarantseva
Russian Journal of Genetics: Applied Research.2014;4(2)113
[DOI]
7Car drivers with dementia: Different complications due to different etiologies?
Dafne Piersma,Dick de Waard,Ragnhild Davidse,Oliver Tucha,Wiebo Brouwer
Traffic Injury Prevention.2016;17(1)9
[DOI]
8Circadian Rhythm and Alzheimer’s Disease
Jan Homolak,Monika Mudrovcic,Barbara Vukic,Karlo Toljan
Medical Sciences.2018;6(3)52
[DOI]
9Flavanone glycosides inhibit ß-site amyloid precursor protein cleaving enzyme 1 and cholinesterase and reduce Aß aggregation in the amyloidogenic pathway
Md Yousof Ali,Susoma Jannat,Najmeh Edraki,Sucharita Das,Won Kyu Chang,Hyun Chul Kim,Seong Kyu Park,Mun Seog Chang
Chemico-Biological Interactions.2019;309(3)108707
[DOI]
10Amyloid-ß induced neuropathological actions are suppressed by Padina gymnospora (Phaeophyceae) and its active constituent a-bisabolol in Neuro2a cells and transgenic Caenorhabditis elegans Alzheimer's model
Balakrishnan Shanmuganathan,Sethuraman Sathya,Boopathi Balasubramaniam,Krishnaswamy Balamurugan,Kasi Pandima Devi
Nitric Oxide.2019;91(3)52
[DOI]
11Development of 2-Methoxyhuprine as Novel Lead for Alzheimer’s Disease Therapy
Eva Mezeiova,Jan Korabecny,Vendula Sepsova,Martina Hrabinova,Petr Jost,Lubica Muckova,Tomas Kucera,Rafael Dolezal,Jan Misik,Katarina Spilovska,Ngoc Pham,Lucia Pokrievkova,Jaroslav Roh,Daniel Jun,Ondrej Soukup,Daniel Kaping,Kamil Kuca
Molecules.2017;22(8)1265
[DOI]
12The PERK-Dependent Molecular Mechanisms as a Novel Therapeutic Target for Neurodegenerative Diseases
Wioletta Rozpedek-Kaminska,Natalia Siwecka,Adam Wawrzynkiewicz,Radoslaw Wojtczak,Dariusz Pytel,J. Alan Diehl,Ireneusz Majsterek
International Journal of Molecular Sciences.2020;21(6)2108
[DOI]
13Copper(I) Chelators for Alzheimer’s Disease
Stanley K. A. Opare,Arvi Rauk
The Journal of Physical Chemistry B.2017;121(50)11304
[DOI]
14Tau Protein and Its Role in Blood–Brain Barrier Dysfunction
Alena Michalicova,Petra Majerova,Andrej Kovac
Frontiers in Molecular Neuroscience.2020;13(50)11304
[DOI]
15Tau Protein and Its Role in Blood–Brain Barrier Dysfunction
Michael R. D’Andrea
Frontiers in Molecular Neuroscience.2015;13(50)1
[DOI]
16Cleistocalyx nervosum var. paniala seed extracts exhibit sigma-1 antagonist sensitive neuroprotective effects in PC12 cells and protect C. elegans from stress via the SKN-1/NRF-2 pathway
James Michael Brimson,Mani Iyer Prasanth,Ciro Isidoro,Monruedee Sukprasansap,Tewin Tencomnao
Nutrition and Healthy Aging.2021;13(50)1
[DOI]
17Novel aspects in structure–activity relationships of profiled 1-aza-9-oxafluorenes as inhibitors of Alzheimer's disease-relevant kinases cdk1, cdk5 and gsk3ß
Volkmar Tell,Kazem Ahmed Mahmoud,Kanin Wichapong,Christoph Schächtele,Frank Totzke,Wolfgang Sippl,Andreas Hilgeroth
MedChemComm.2012;3(11)1413
[DOI]
18Anti-Cholinesterase Potential of Standardized Extract of PHELA a Traditional South African Medicine Formulation
Bhaskar Das,Amit Kar,Motlalepula G. Matsabisa,Pulok K. Mukherjee
Journal of Herbal Medicine.2020;22(11)100348
[DOI]
19Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review
Jorge Berlanga-Acosta,Gerardo Guillén-Nieto,Nadia Rodríguez-Rodríguez,Maria Luisa Bringas-Vega,Diana García-del-Barco-Herrera,Jorge O. Berlanga-Saez,Ariana García-Ojalvo,Mitchell Joseph Valdés-Sosa,Pedro A. Valdés-Sosa
Frontiers in Endocrinology.2020;11(11)100348
[DOI]
20How sodium arsenite improve amyloid ß-induced memory deficit?
Ehsan Nassireslami,Parmida Nikbin,Elham Amini,Borna Payandemehr,Fatemeh Shaerzadeh,Fariba Khodagholi,Behnoosh Bonakdar Yazdi,Abbas Kebriaeezadeh,Ghorban Taghizadeh,Mohammad Sharifzadeh
Physiology & Behavior.2016;163(11)97
[DOI]
21Naphthoquinone Tryptophan Hybrids: A Promising Small Molecule Scaffold for Mitigating Aggregation of Amyloidogenic Proteins and Peptides
Guru KrishnaKumar Viswanathan,Ashim Paul,Ehud Gazit,Daniel Segal
Frontiers in Cell and Developmental Biology.2019;7(11)97
[DOI]
22Analysis of post-translational modifications in Alzheimer's disease by mass spectrometry
Andrea Renee Kelley,Stephan B.H. Bach,George Perry
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2019;1865(8)2040
[DOI]
23Telomerase gene therapy ameliorates the effects of neurodegeneration associated to short telomeres in mice
Kurt Whittemore,Aksinya Derevyanko,Paula Martinez,Rosa Serrano,Martí Pumarola,Fàtima Bosch,Maria A. Blasco
Aging.2019;11(10)2916
[DOI]
24Therapeutic Potentials of Microalgae in the Treatment of Alzheimer’s Disease
Tosin Olasehinde,Ademola Olaniran,Anthony Okoh
Molecules.2017;22(3)480
[DOI]
25Therapeutic Potentials of Microalgae in the Treatment of Alzheimer’s Disease
Tahira Farooqui,Akhlaq A. Farooqui
Molecules.2018;22(3)253
[DOI]
26Mechanism, Diagnosis, Medication, Care Guidance, and Health Promotion in Alzheimer’s Disease
Dong Yue,S.O. Oladokun,S. Lu
E3S Web of Conferences.2020;218(3)03047
[DOI]
27Backward genotype-transcript-phenotype association mapping
Seunghak Lee,Haohan Wang,Eric P. Xing
Methods.2017;129(3)18
[DOI]
28Integrating music-based interventions with Gamma-frequency stimulation: Implications for healthy ageing
Parker Tichko,Ji Chul Kim,Edward Large,Psyche Loui
European Journal of Neuroscience.2020;129(3)18
[DOI]
29Anti-amyloidogenic and anti-apoptotic effect of a-bisabolol against Aß induced neurotoxicity in PC12 cells
Balakrishnan Shanmuganathan,Venkatesan Suryanarayanan,Sethuraman Sathya,Muralidharan Narenkumar,Sanjeev Kumar Singh,Kandasamy Ruckmani,Kasi Pandima Devi
European Journal of Medicinal Chemistry.2018;143(3)1196
[DOI]
30Neuroprotective Approach of Anti-Cancer Microtubule Stabilizers Against Tauopathy Associated Dementia: Current Status of Clinical and Preclinical Findings
Pallavi Duggal,Sidharth Mehan
Journal of Alzheimer's Disease Reports.2019;3(1)179
[DOI]
31Autophagy in Stem Cell Biology: A Perspective on Stem Cell Self-Renewal and Differentiation
Xihang Chen,Yunfan He,Feng Lu
Stem Cells International.2018;2018(1)1
[DOI]
32Isorhamnetin enhanced cortico-hippocampal learning and memory capability in mice with scopolamine-induced amnesia: Role of antioxidant defense, cholinergic and BDNF signaling
Ismail O. Ishola,Mmesomachukwu O. Osele,Micah C. Chijioke,Olufunmilayo O. Adeyemi
Brain Research.2019;1712(1)188
[DOI]
33Update and review of the gerodontology prospective for 2020's: Linking the interactions of oral (hypo)-functions to health vs. systemic diseases
Yen Chun G. Liu,Shou-Jen Lan,Hirohiko Hirano,Li-min Lin,Kazuhiro Hori,Chia-shu Lin,Samuel Zwetchkenbaum,Shunsuke Minakuchi,Andy Yen-Tung Teng
Journal of Dental Sciences.2020;1712(1)188
[DOI]
34Chronic low dose of AM404 ameliorates the cognitive impairment and pathological features in hyperglycemic 3xTg-AD mice
Hei-Jen Huang,Shu-Ling Chen,Hsin-Yu Huang,Ying-Chieh Sun,Guan-Chiun Lee,Guey-Jen Lee-Chen,Hsiu Mei Hsieh-Li,Ming-Tsan Su
Psychopharmacology.2019;236(2)763
[DOI]
35Receptor-Interacting Protein Kinase 1 (RIPK1) as a Potential Therapeutic Target: An Overview of Its Possible Role in the Pathogenesis of Alzheimer's Disease
Hong Hao Chan,Rhun Yian Koh,Chooi Ling Lim,Chee Onn Leong
Current Alzheimer Research.2019;16(10)907
[DOI]
36The Recent Updates of Therapeutic Approaches Against Aß for the Treatment of Alzheimer's Disease
Shucai Ling,Jing Zhou,John A. Rudd,Zhiying Hu,Marong Fang
The Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology.2011;294(8)1307
[DOI]
37Alzheimer’s Disease: An Overview of Major Hypotheses and Therapeutic Options in Nanotechnology
Mugdha Agarwal,Mohammad Rizwan Alam,Mohd Kabir Haider,Md. Zubbair Malik,Dae-Kwang Kim
Nanomaterials.2020;11(1)59
[DOI]
38ROLE OF PATHOGENIC PROTEINS AND CHRONIC INFLAMMATION IN THE OCCURRENCE OF ALZHEIMER'S DISEASE
A.P. Denysenko,O.O. Haikova,R.A. Moskalenko
Eastern Ukrainian Medical Journal.2020;8(4)475
[DOI]
39Volume Analysis of Brain Cognitive Areas in Alzheimer’s Disease: Interim 3-Year Results from the ASCOMALVA Trial
Enea Traini,Anna Carotenuto,Angiola Maria Fasanaro,Francesco Amenta
Journal of Alzheimer's Disease.2020;76(1)317
[DOI]
40Evaluation of urinary 8-hydroxy-2-deoxyguanosine level in experimental Alzheimer’s disease: Impact of carvacrol nanoparticles
Dalia Medhat,Hatem A. El-mezayen,Mehrez E. El-Naggar,Abdel Razik Farrag,Mohamed Essameldin Abdelgawad,Jihan Hussein,Marina Hanna Kamal
Molecular Biology Reports.2019;46(4)4517
[DOI]
41Circadian and sleep dysfunction in Alzheimer’s disease
Md. Sahab Uddin,Devesh Tewari,Abdullah Al Mamun,Md. Tanvir Kabir,Kamal Niaz,Mir Imam Ibne Wahed,George E. Barreto,Ghulam Md. Ashraf
Ageing Research Reviews.2020;60(4)101046
[DOI]
42Mitochondrial permeability transition pore: a potential drug target for neurodegeneration
Komal Kalani,Shi Fang Yan,Shirley ShiDu Yan
Drug Discovery Today.2018;23(12)1983
[DOI]
43Intrinsic Origin of Tau Protein Aggregation: Effects of Histidine Tautomerism on Tau267–312 Monomer
Sompriya Chatterjee,Abbas Salimi,Jin Yong Lee
ACS Chemical Neuroscience.2020;11(22)3814
[DOI]
44Newly Developed Drugs for Alzheimer’s Disease in Relation to Energy Metabolism, Cholinergic and Monoaminergic Neurotransmission
Jan Korábecný,Eugenie Nepovimová,Tereza Cikánková,Katarína Špilovská,Lucie Vašková,Eva Mezeiová,Kamil Kuca,Jana Hroudová
Neuroscience.2018;370(22)191
[DOI]
45Experimental evidence for the potential of lycopene in the management of scopolamine induced amnesia
Rajni Bala,Deepa Khanna,Sidharth Mehan,Sanjeev Kalra
RSC Advances.2015;5(89)72881
[DOI]
46KRICT-9 inhibits neuroinflammation, amyloidogenesis and memory loss in Alzheimer’s disease models
Do Yeon Lee,Chul Ju Hwang,Ji Yeon Choi,Mi Hee Park,Min Ji Song,Ki Wan Oh,Sang Bae Han,Woo Kyu Park,Hee Yeong Cho,Sung Yun Cho,Hye Byn Park,Min Jong Song,Jin Tae Hong
Oncotarget.2017;8(40)68654
[DOI]
47KRICT-9 inhibits neuroinflammation, amyloidogenesis and memory loss in Alzheimer’s disease models
Satya Narayan Sahu,Maheswata Moharana,Sushma Rani Martha,Akalabya Bissoyi,Pradeep Kumar Maharana,Subrat Kumar Pattanayak
Oncotarget.2019;8(40)247
[DOI]
48Alzheimer Hastaligi ile Iliskilendirilen APH1A Genindeki Zararli SNP’lerin In Silico Yöntemler ile Belirlenmesi
EBRU ÖZKAN OKTAY,Tugba KAMAN,Ömer Faruk KARASAKAL,Korkut ULUCAN,Muhsin KONUK,Nevzat TARHAN
Süleyman Demirel Üniversitesi Fen Bilimleri Enstitüsü Dergisi.2019;8(40)196
[DOI]
49Attenuation of Nrf2/Keap1/ARE in Alzheimer’s Disease by Plant Secondary Metabolites: A Mechanistic Review
Sajad Fakhri,Mirko Pesce,Antonia Patruno,Seyed Zachariah Moradi,Amin Iranpanah,Mohammad Hosein Farzaei,Eduardo Sobarzo-Sánchez
Molecules.2020;25(21)4926
[DOI]
50Pro-oxidant status based alterations in cerebellar antioxidant response to aluminum insult
P. Nayak,S. B. Sharma,N. V. S. Chowdary
Neurochemical Journal.2012;6(1)44
[DOI]
51M344 promotes nonamyloidogenic amyloid precursor protein processing while normalizing Alzheimer’s disease genes and improving memory
Claude-Henry Volmar,Hasib Salah-Uddin,Karolina J. Janczura,Paul Halley,Guerline Lambert,Andrew Wodrich,Sivan Manoah,Nidhi H. Patel,Gregory C. Sartor,Neil Mehta,Nancy T. H. Miles,Sachi Desse,David Dorcius,Michael D. Cameron,Shaun P. Brothers,Claes Wahlestedt
Proceedings of the National Academy of Sciences.2017;114(43)E9135
[DOI]
52The GABAergic system as a therapeutic target for Alzheimer's disease
Beatriz Calvo-Flores Guzmán,Chitra Vinnakota,Karan Govindpani,Henry J. Waldvogel,Richard L.M. Faull,Andrea Kwakowsky
Journal of Neurochemistry.2018;146(6)649
[DOI]
53Age related neurodegenerative Alzheimer’s disease: Usage of traditional herbs in therapeutics
Abhishek Singh,Sindhu Agarwal,Sarika Singh
Neuroscience Letters.2020;717(6)134679
[DOI]
54Artemisia amygdalina Upregulates Nrf2 and Protects Neurons Against Oxidative Stress in Alzheimer Disease
Nasreena Sajjad,Abubakar Wani,Ankita Sharma,Rohaya Ali,Sumaya Hassan,Rabia Hamid,Huma Habib,Bashir Ahmad Ganai
Cellular and Molecular Neurobiology.2019;39(3)387
[DOI]
55Cholinesterase inhibitory, anti-amyloidogenic and neuroprotective effect of the medicinal plant Grewia tiliaefolia – An in vitro and in silico study
Dicson Sheeja Malar,Rajamohamed Beema Shafreen,Shunmugiah Karutha Pandian,Kasi Pandima Devi
Pharmaceutical Biology.2017;55(1)381
[DOI]
56Advancements of the sFIDA method for oligomer-based diagnostics of neurodegenerative diseases
Andreas Kulawik,Henrike Heise,Christian Zafiu,Dieter Willbold,Oliver Bannach
FEBS Letters.2018;592(4)516
[DOI]
57Indian research on aging and dementia
KS Shaji,VP Jithu,KS Jyothi
Indian Journal of Psychiatry.2010;52(7)148
[DOI]
58NEDD9 is genetically associated with Alzheimer's disease in a Han Chinese population
Yao-Yao Xing,Jin-Tai Yu,Wen-Jing Yan,Wei Chen,Xiao-Ling Zhong,Hong Jiang,Ping Wang,Lan Tan
Brain Research.2011;1369(7)230
[DOI]
59Insights into lncRNAs in Alzheimer’s disease mechanisms
Dingfeng Li,Juan Zhang,Xiaohui Li,Yuhua Chen,Feng Yu,Qiang Liu
RNA Biology.2020;1369(7)1
[DOI]
60Unlocking the concealed targets using system biology mapping for Alzheimer’s disease
Poorvashree Joshi,Vikram Kawade,Sivakami Dhulap,Mandakini Goel
Pharmacological Reports.2019;71(6)1104
[DOI]
61Cerebrovascular inflammation is associated with tau pathology in Guam parkinsonism dementia
Petra Majerova,Ralph M. Garruto,Andrej Kovac
Journal of Neural Transmission.2018;125(7)1013
[DOI]
62Ameliorating effect of lyophilized extract ofButea frondosaleaves on scopolamine-induced amnesia in rats
Jai Malik,Munish Kumar,Rahul Deshmukh,Puneet Kumar
Pharmaceutical Biology.2013;51(2)233
[DOI]
63Xenobiotics, Trace Metals and Genetics in the Pathogenesis of Tauopathies
Jan Aaseth,Aleksandra Buha,David R. Wallace,Geir Bjørklund
International Journal of Environmental Research and Public Health.2020;17(4)1269
[DOI]
64Therapeutic Effects of Curcumin on Alzheimer’s Disease
Edward C. Yao,Lei Xue
Advances in Alzheimer's Disease.2014;03(04)145
[DOI]
65Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends
Sergey O. Bachurin,Elena V. Bovina,Aleksey A. Ustyugov
Medicinal Research Reviews.2017;37(5)1186
[DOI]
66Low-Frequency Pulsed Electromagnetic Field Is Able to Modulate miRNAs in an Experimental Cell Model of Alzheimer’s Disease
Enrica Capelli,Filippo Torrisi,Letizia Venturini,Maria Granato,Lorenzo Fassina,Giuseppe Francesco Damiano Lupo,Giovanni Ricevuti
Journal of Healthcare Engineering.2017;2017(5)1
[DOI]
67Kalsinörin Mekanizmasi ve Kalsinörin Inhibitörlerinin Alzheimer Hastaliginin Tedavisindeki Önemi
Fatma Gonca KOÇANCI,Belma ASLIM
SDÜ Tip Fakültesi Dergisi.2017;2017(5)1
[DOI]
68Nootropic activity of acetaminophen against colchicine induced cognitive impairment in rats
Vigneshwaran Pitchaimani,Somasundaram Arumugam,Rajarajan A. Thandavarayan,Manisenthilkumar K. Thiyagarajan,Rajasekaran Aiyalu,Remya Sreedhar,Takashi Nakamura,Kenichi Watanabe
Journal of Clinical Biochemistry and Nutrition.2012;50(3)241
[DOI]
69Nootropic activity of acetaminophen against colchicine induced cognitive impairment in rats
Chyn Boon Wong,Yodai Kobayashi,Jin-zhong Xiao
Journal of Clinical Biochemistry and Nutrition.2018;50(3)241
[DOI]
70Nootropic activity of acetaminophen against colchicine induced cognitive impairment in rats
Sethuraman Sathya,Kasi Pandima Devi
Journal of Clinical Biochemistry and Nutrition.2018;50(3)239
[DOI]
71Strategizing the Development of Alzheimer’s Therapeutics
Justin Davis,Robin Couch
Advances in Alzheimer's Disease.2014;03(03)107
[DOI]
72Gamma-aminobutyric acid A receptors in Alzheimer's disease: highly localized remodeling of a complex and diverse signaling pathway
Andrea Kwakowsky,Beatriz Calvo-Flores Guzmán,Karan Govindpani,HenryJ Waldvogel,RichardL Faull
Neural Regeneration Research.2018;13(8)1362
[DOI]
73Apolipoprotein E Polymorphism and Oxidative Stress in Peripheral Blood-Derived Macrophage-Mediated Amyloid-Beta Phagocytosis in Alzheimer’s Disease Patients
P. S. Jairani,P. M. Aswathy,Dhanya Krishnan,Ramsekhar N. Menon,Joe Verghese,P. S. Mathuranath,Srinivas Gopala
Cellular and Molecular Neurobiology.2019;39(3)355
[DOI]